On Jun 29, 2018 34.99 % to Target, Endo International (NASDAQ:ENDP) Stock Buy Rating Reaffirmed by B. Riley FBR.

June 29, 2018 - By Heather Owens

Endo International plc (NASDAQ:ENDP) Corporate Logo

Big Money Sentiment decreased to 1.07 in 2018 Q1. It has change of 0.06, from 2017Q4’s 1.13. The ratio is negative due to Endo International plc positioning: 25 sold and 70 reduced. 33 funds acquired positions and 69 increased positions. Investors holded 203.77 million in 2017Q4 but now own 213.17 million shares or 4.61% more.

110,870 are owned by Trexquant Invest Lp. First Quadrant Limited Partnership Ca owns 1.39 million shs. 1832 Asset Mgmt Ltd Partnership reported 0% in Endo International plc (NASDAQ:ENDP). Nomura holds 1.34 million shs. Oak Associate Ltd Oh holds 0.07% or 169,570 shs in its capital. 229,000 were reported by Gabelli Funds Limited Com. Amer Fincl Grp Inc invested in 227,190 shs or 0.13% of the stock. Guggenheim Ltd Liability, Illinois-based fund reported 40,373 shs. Public Employees Retirement Association Of Colorado reported 41,870 shs. Dekabank Deutsche Girozentrale holds 104,200 shs or 0% of its capital. 133,068 were reported by Texas Permanent School Fund. Northern Tru holds 0% or 1.72M shs in its capital. Ls Invest Advsrs Ltd holds 4,253 shs or 0% of its capital. Earnest Prns Limited Co accumulated 87 shs. Principal Financial Group Inc has 0.01% invested in Endo International plc (NASDAQ:ENDP) for 891,037 shs.

Reiterated Endo International (NASDAQ:ENDP) Rating.

Endo International (NASDAQ:ENDP) had $13 target given by B. Riley FBR in a research report published on Thursday morning. Research professionals’s price target indicates a potential upside of 34.99 % from the company’s current price.

Endo International plc (NASDAQ:ENDP) Ratings Coverage

In total 11 analysts cover Endo International (NASDAQ:ENDP). “Buy” rating has 3, “Sell” are 0, while 8 are “Hold”. 27% are bullish. 14 are the (NASDAQ:ENDP)’s analyst reports since January 3, 2018 according to StockzIntelligence Inc. In Thursday, June 28 report FBR Capital maintained the stock with “Buy” rating. On Wednesday, April 4 the rating was downgraded by Mizuho to “Neutral”. On Wednesday, February 28 the company was downgraded by Gabelli. On Wednesday, February 28 the stock of Endo International plc (NASDAQ:ENDP) earned “Hold” rating by William Blair. On Friday, January 19 the company was maintained by Mizuho. On Wednesday, February 21 the rating was maintained by Canaccord Genuity with “Hold”. On Wednesday, January 3 the stock of Endo International plc (NASDAQ:ENDP) earned “Buy” rating by Mizuho. On Friday, February 23 the stock of Endo International plc (NASDAQ:ENDP) earned “Equal-Weight” rating by Barclays Capital. The company rating was initiated by FBR Capital on Tuesday, February 13. On Monday, March 5 BMO Capital Markets maintained the shares of ENDP in report with “Market Perform” rating.

ENDP is reaching $9.63 during the last trading session, after decreased 2.03%.Currently Endo International plc is downtrending after 51.05% change in last June 29, 2017. ENDP has also 3.02M shares volume. ENDP underperformed by 63.62% the S&P500.

Endo International plc (NASDAQ:ENDP)’s earnings report is expected on August, 14., as reported by Faxor. Analysts expect change of 41.94 % or $0.39 from previous year’s $0.93 earnings per share compared to current’s $0.54 earnings per share. The profit will be $120.84 million for ENDP if $0.54 earnings per share becomes true. -19.40 % negative EPS growth is what Wall Street’s sees after $0.67 reported EPS last quarter.

Endo International plc, a specialty pharmaceutical company, makes and sells generic and branded pharmaceuticals in the United States, Canada, and internationally.The firm is worth $2.16 billion. The firm operates through three divisions: U.S.Currently it has negative earnings. Generic Pharmaceuticals, U.S.

For more Endo International plc (NASDAQ:ENDP) news released briefly go to: Streetinsider.com, Benzinga.com, Profitconfidential.com, Fool.com or Seekingalpha.com. The titles are as follows: “Endo (ENDP) Reports Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement …” released on June 11, 2018, “Endo Wins Citi Upgrade On Positive Catalysts, Cellulite Treatment Opportunity” on June 27, 2018, “These Indications Suggest That ENDP Stock Has Finally Found a Bottom” with a publish date: June 14, 2018, “Why Endo International plc Rocketed Higher Today” and the last “Buy Alibaba – Cramer’s Lightning Round (6/12/18)” with publication date: June 13, 2018.

Endo International plc (NASDAQ:ENDP) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.